JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706543200 on August 29, 2007

J. Biol. Chem., Vol. 282, Issue 45, 32539-32548, November 9, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/45/32539    most recent
M706543200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, M. J.
Right arrow Articles by Carling, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, M. J.
Right arrow Articles by Carling, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Defining the Mechanism of Activation of AMP-activated Protein Kinase by the Small Molecule A-769662, a Member of the Thienopyridone Family*

Matthew J. Sanders{ddagger}1, Zahabia S. Ali{ddagger}2, Bronwyn D. Hegarty{ddagger}3, Richard Heath{ddagger}4, Michael A. Snowden§, and David Carling{ddagger}5

From the {ddagger}Cellular Stress Group, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Imperial College, DuCane Road, London W12 0NN and §Screening and Compound Profiling, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, CM19 5AW, United Kingdom

AMP-activated protein kinase (AMPK) plays a key role in maintaining energy homeostasis. Activation of AMPK in peripheral tissues has been shown to alleviate the symptoms of metabolic diseases, such as type 2 diabetes, and consequently AMPK is a target for treatment of these diseases. Recently, a small molecule activator (A-769662) of AMPK was identified that had beneficial effects on metabolism in ob/ob mice. Here we show that A-769662 activates AMPK both allosterically and by inhibiting dephosphorylation of AMPK on Thr-172, similar to the effects of AMP. A-769662 activates AMPK harboring a mutation in the {gamma} subunit that abolishes activation by AMP. An AMPK complex lacking the glycogen binding domain of the beta subunit abolishes the allosteric effect of A-769662 but not the allosteric activation by AMP. Moreover, mutation of serine 108 to alanine, an autophosphorylation site within the glycogen binding domain of the beta1 subunit, almost completely abolishes activation of AMPK by A-769662 in cells and in vitro, while only partially reducing activation by AMP. Based on our results we propose a model for activation of AMPK by A-769662. Importantly, this model may provide clues for understanding the mechanism by which AMP leads to activation of AMPK, which in turn may help in the identification of other AMPK activators.


Received for publication, August 7, 2007 , and in revised form, August 29, 2007.

* This work was supported in part by the Medical Research Council UK and the European Commission Grants LSHM-CT-2004-005272 and LSH-CT-2005-518181. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a Biotechnology and Biological Sciences Research Council-Collaborative Awards in Science and Engineering Ph.D. studentship.

2 Recipient of a Medical Research Council Ph.D. studentship.

3 Present address: Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, New South Wales 2021, Australia.

4 Present address: Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.

5 To whom correspondence should be addressed. Tel.: 44-2083834313; Fax: 44-2083838514; E-mail: dcarling{at}csc.mrc.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
U. Riek, R. Scholz, P. Konarev, A. Rufer, M. Suter, A. Nazabal, P. Ringler, M. Chami, S. A. Muller, D. Neumann, et al.
Structural Properties of AMP-activated Protein Kinase: DIMERIZATION, MOLECULAR SHAPE, AND CHANGES UPON LIGAND BINDING
J. Biol. Chem., June 27, 2008; 283(26): 18331 - 18343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Thornton, A. Sardini, and D. Carling
Muscarinic Receptor Activation of AMP-activated Protein Kinase Inhibits Orexigenic Neuropeptide mRNA Expression
J. Biol. Chem., June 20, 2008; 283(25): 17116 - 17122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Pang, Z.-S. Zhang, M. Gu, B.-Y. Qiu, L.-F. Yu, P.-R. Cao, W. Shao, M.-B. Su, J.-Y. Li, F.-J. Nan, et al.
Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in Cells
J. Biol. Chem., June 6, 2008; 283(23): 16051 - 16060.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.